Delayed Diagnosis of Congenital Sideroblastic Anemia
A 65-year-old female of Italian and Danish ancestry was referred to our hematology clinic for evaluation of macrocytic anemia and iron overload. Family history was remarkable for anemia in her mother and sister. Her past medical history was significant for anemia since childhood. During her youth she was treated with vitamin B12 supplements without improvement. She was found to have a high transferrin saturation and ferritin and was diagnosed with hemochromatosis by an outside hematologist. However, she tested negative for the C282Y, H63D and S65C hemochromatosis mutations. (Source: Seminars in Hematology)
Source: Seminars in Hematology - October 13, 2017 Category: Hematology Authors: Ghaith Abu-Zeinah, Mustafa Al-Kawaaz, Julia Geyer, Maria T. DeSancho Source Type: research
outside front cover, PMS 8883 metallic AND 4/C
(Source: Seminars in Hematology)
Source: Seminars in Hematology - October 1, 2017 Category: Hematology Source Type: research
Masthead
(Source: Seminars in Hematology)
Source: Seminars in Hematology - October 1, 2017 Category: Hematology Source Type: research
Table of Contents
(Source: Seminars in Hematology)
Source: Seminars in Hematology - October 1, 2017 Category: Hematology Source Type: research
outside front cover, PMS 8883 metallic AND 4/C
(Source: Seminars in Hematology)
Source: Seminars in Hematology - October 1, 2017 Category: Hematology Source Type: research
Masthead
(Source: Seminars in Hematology)
Source: Seminars in Hematology - October 1, 2017 Category: Hematology Source Type: research
Table of Contents
(Source: Seminars in Hematology)
Source: Seminars in Hematology - October 1, 2017 Category: Hematology Source Type: research
Patient assistance programs: a valuable, yet imperfect, way to ease the financial toxicity of cancer care
High out-of-pocket (OOP) spending on cancer drugs is a known contributor to "financial toxicity" among cancer patients. Many predict that this problem will only worsen as patients continue to bear more responsibility for the cost of their medical care and as the use of oral chemotherapeutic agents increases. Although foundations and pharmaceutical companies offer patient assistance programs (PAPs) to improve drug affordability, the degree to which these programs are used is poorly understood. There are several barriers to the use of PAPs that not only affect access to patients who may benefit but also create limitations on...
Source: Seminars in Hematology - September 20, 2017 Category: Hematology Authors: Todd Yezefski, Ann Schwemm, Michelle Lentz, Katie Hone, Veena Shankaran Source Type: research
Patient Assistance Programs —A valuable, yet imperfect, way to ease the financial toxicity of cancer care
High out-of-pocket (OOP) spending on cancer drugs is a known contributor to financial toxicity among cancer patients. Many predict that this problem will only worsen as patients continue to bear more responsibility for the cost of their medical care and as the use of oral chemotherapeutics increases. While foundations and pharmaceutical companies offer patient assistance programs (PAPs) to improve drug affordability, the degree to which these programs are utilized is poorly understood. There are several barriers to the use of PAPs that not only affect access to patients who may benefit, but also create limitations on the r...
Source: Seminars in Hematology - September 20, 2017 Category: Hematology Authors: Todd Yezefski, Ann Schwemm, Michelle Lentz, Katie Hone, Veena Shankaran Source Type: research
Impact of social media for the hematologist/oncologist
In the era of modern communication, the physician and patient relationship has evolved to include an entirely new dimension —social media. This new dimension offers several opportunities for patient education, research and its dissemination, and professional development for health care providers; it can also serve as a platform for addressing important public health issues. However, these advantages come with challenge s such as threats to patient and professional privacy. In this article, we dissect the benefits and drawbacks of this social evolution on the practicing hematologist-oncologist. (Source: Seminars in Hematology)
Source: Seminars in Hematology - September 15, 2017 Category: Hematology Authors: Nour Abuhadra, Navneet S. Majhail, Aziz Nazha Source Type: research
Impact of Social Media for the Hematologist/Oncologist
In the era of modern communication, the physician and patient relationship has evolved to include an entirely new dimension – social media. This new dimension offers several opportunities for patient education, research and its dissemination, professional development for healthcare providers and can serve as a platform for addressing important public health issues. However, these advantages come with challenges such as threats to patient and professional privacy. We dissect the benefits and drawbacks of this social evolution on the practicing hematologist-oncologists. (Source: Seminars in Hematology)
Source: Seminars in Hematology - September 15, 2017 Category: Hematology Authors: Nour Abuhadra, Navneet S. Majhail, Aziz Nazha Source Type: research
Disease-specific hashtags and the creation of Twitter medical communities in hematology and oncology
Twitter is being increasingly used for information gathering and dissemination of ideas in both medical practice and scientific research. A major limitation to its use has been the surplus of available information and difficulty in categorizing that information into topics of individual interest. However, a Twitter feature known as the hashtag (#), which denotes a specific category or topic, helps in streamlining this wealth of information. The creation and adoption of disease-specific hashtags by healthcare stakeholders has led to a greater uniformity of medical discussions that can be retrieved and referenced at later ti...
Source: Seminars in Hematology - August 29, 2017 Category: Hematology Authors: Naveen Pemmaraju, Michael A. Thompson, Muzaffar Qazilbash Source Type: research
Disease-Specific Hashtags and the Creation of Twitter Medical Communities in Hematology and Oncology
Twitter is being increasingly used for information gathering and dissemination of ideas in both medical practice and scientific research. A major limitation to its use has been the surplus of available information and difficulty in categorizing that information into topics of individual interest. However, a Twitter feature known as the hashtag (#), which denotes a specific category or topic, helps in streamlining this wealth of information. The creation and adoption of disease-specific hashtags by healthcare stakeholders has led to a greater uniformity of medical discussions that can be retrieved and referenced at later ti...
Source: Seminars in Hematology - August 29, 2017 Category: Hematology Authors: Naveen Pemmaraju, Michael A. Thompson, Muzaffar Qazilbash Source Type: research
Editorial overview: Emerging importance of social media for real-time communication in the modern medical era
Data from the Pew Research Center, approximately 70% of Americans are using social media platforms for connection and communication [1,2]. Remarkably, in 2005, at the time this information was first collected, only 5% of Americans were engaging in social media [1]. Additionally, it is becoming increasingly clear that communication via the Internet and social media are mainstays of of the modern medical era, both in clinical practice [3] and for the conduction and reporting of academic medical research [4,5]. (Source: Seminars in Hematology)
Source: Seminars in Hematology - August 25, 2017 Category: Hematology Authors: Naveen Pemmaraju Source Type: research
